Introduction: Who Should Seek Diagnostic Evaluation

If you have chronic kidney disease, especially advanced kidney disease or end-stage kidney disease requiring dialysis, and you’re experiencing persistent itching, it’s important to talk to your doctor. This type of itching, known as chronic kidney disease-associated pruritus or CKD-aP, affects a significant number of kidney patients. Studies show that up to 70% of people receiving hemodialysis experience some degree of itching, and around 25% of people with chronic kidney disease who aren’t yet on dialysis also suffer from this symptom.^[5]

You should seek diagnostic evaluation if you’re experiencing itching that lasts day after day or nearly every day, especially if there’s no obvious skin rash or condition causing it. The itching might affect your entire body or specific areas like your back, face, or the arm where you receive dialysis. It can come and go, or it might be constant. Some people find the itching gets worse when their skin is dry or during certain times related to their dialysis treatment.^[3]

People on hemodialysis are at higher risk than those on peritoneal dialysis or those not yet on dialysis. Some research suggests that individuals over 70 years old may be more likely to experience this type of itching and may have more severe symptoms. However, CKD-associated pruritus can affect kidney patients at various stages of their disease journey.^[5]

It’s especially important to seek medical attention if the itching is affecting your quality of life. Many people with CKD-aP report that it disrupts their sleep, affects their mood, and can lead to feelings of depression. The constant urge to scratch can also lead to skin damage, increasing your risk of infections. Because the itching is linked to poor treatment adherence and worse health outcomes, early diagnosis and management are essential.^[2]

Classic Diagnostic Methods for Identifying CKD-Associated Pruritus

Diagnosing chronic kidney disease-associated pruritus is largely a process of elimination, meaning doctors must first rule out other possible causes of itching before confirming that your symptoms are related to your kidney disease. This approach is necessary because CKD-aP is defined as moderate to severe itching directly related to kidney disease, without the presence of any other condition that typically causes itching.^[3]

Clinical Evaluation and Patient History

The diagnostic process typically begins with a thorough conversation between you and your doctor. Your healthcare provider will ask detailed questions about your itching: when it started, how long it lasts, what times of day it occurs, whether it happens before, during, or after dialysis, and which parts of your body are affected. They’ll also want to know how severe the itching is and how it’s impacting your daily life, including your sleep and emotional wellbeing.^[3]

One of the defining characteristics of CKD-associated pruritus is that it’s commonly experienced daily or near-daily without a primary skin problem causing it. The itching can be localized to specific areas or generalized across your whole body. Your back, face, and the arm where you receive dialysis (if you’re on hemodialysis) are among the most commonly affected spots.^[2]

The severity and frequency of itching can vary considerably over time, ranging from mild and occasional to severe and constant. This variability can actually make diagnosis more challenging, which is why keeping track of when and where you itch can be helpful information to share with your doctor.^[3]

Physical Skin Examination

Your doctor will carefully examine your skin looking for rashes, lesions, or other visible changes that might explain the itching. In the early stages of CKD-associated pruritus, the skin typically appears normal—there’s no rash or other obvious skin condition present. This absence of visible skin changes is actually an important clue in diagnosing CKD-aP.^[4]

However, if you’ve been experiencing itching for a long time and have been scratching persistently, your doctor may see secondary changes to your skin. These can include excoriations, which are scratches or abrasions on the skin surface, or in severe cases, nodular prurigo, which are raised bumps that develop from chronic scratching. If your doctor notices visible skin changes like a rash, they’ll need to investigate other possible causes for your itching.^[4]

Ruling Out Other Causes of Itching

Before confirming a diagnosis of CKD-associated pruritus, it’s crucial to exclude other medical conditions that can cause itching. Several skin conditions can produce similar symptoms, including eczema, psoriasis, and infections like scabies. Your doctor will evaluate whether any of these conditions might be present.^[4]

Beyond skin diseases, other medical conditions can cause chronic itching. Liver disease, thyroid disorders, and atopy (a genetic tendency toward allergic conditions) are all potential causes that need to be ruled out. Your doctor will consider your overall medical history and may review your medication list, as some drugs—particularly morphine-based painkillers—can cause itching as a side effect.^[2]

Blood tests may be ordered to check for these alternative causes. These tests might include liver function tests, thyroid function tests, and other laboratory work to look for underlying conditions that could explain your symptoms. The goal is to ensure that the itching is truly related to your kidney disease and not to another treatable condition.^[5]

Best practice in the kidney care community is for physicians to consider any itching in dialysis patients as likely being related to CKD-aP unless there’s a clear alternative explanation. This approach helps ensure that this often-overlooked condition is recognized and addressed rather than dismissed.^[3]

Understanding the Diagnostic Challenge

Diagnosing CKD-associated pruritus can be particularly difficult because the condition has several unique characteristics that complicate identification. The itching may occur at any time in relation to dialysis—before, during, or after your treatment session. The severity can fluctuate unpredictably from mild to moderate to severe. Additionally, different body parts may be affected at different times.^[3]

Perhaps most challenging is that no visual presentation on the skin may occur initially, although persistent scratching will eventually create visible marks and lesions. This lack of obvious physical signs means that healthcare providers must rely heavily on your description of symptoms and your medical history to make the diagnosis.^[3]

Diagnostics for Clinical Trial Qualification

When researchers design clinical trials to test new treatments for chronic kidney disease-associated pruritus, they need standardized ways to identify which patients are suitable candidates and to measure whether treatments are working. The diagnostic criteria used in clinical trials are often more specific and detailed than those used in everyday clinical practice.

Establishing Kidney Disease Status

Clinical trials for CKD-associated pruritus typically require participants to have confirmed chronic kidney disease or end-stage renal disease. This means you would need documentation of your kidney function, usually through blood tests that measure your kidney’s filtering ability. Standard kidney tests include measurements of serum creatinine and calculation of your estimated glomerular filtration rate (eGFR), which indicates how well your kidneys are filtering waste from your blood.^[2]

For trials focusing specifically on dialysis patients, you would need to be established on a regular dialysis schedule, whether hemodialysis or peritoneal dialysis. The trial protocols often specify minimum durations of time you must have been on dialysis to qualify, as this helps ensure that your itching is truly related to kidney disease and not a temporary reaction to starting treatment.

Confirming and Measuring Pruritus

Clinical trials need objective ways to confirm that participants have CKD-associated pruritus and to measure its severity. Researchers commonly use standardized questionnaires and scales that ask you to rate your itching intensity, frequency, and impact on your quality of life. These tools help ensure that all participants meet a minimum threshold of symptom severity and provide a consistent way to track whether symptoms improve during the trial.

Trial protocols typically require that you’ve been experiencing itching for a specific minimum period, such as several weeks or months, to ensure the condition is chronic rather than temporary. You may be asked to keep a diary tracking your itching symptoms for a period before the trial begins, which helps establish a baseline against which treatment effects can be measured.

Excluding Other Conditions

Just as in routine clinical diagnosis, clinical trials require thorough evaluation to exclude other causes of itching. Trial participants typically undergo blood tests to rule out liver disease, thyroid disorders, and other medical conditions that could cause similar symptoms. A detailed medication review is conducted to ensure that itching isn’t a side effect of drugs you’re taking.^[2]

Skin examination is performed to document the absence of primary skin diseases like eczema or psoriasis that could explain the itching. If you have secondary skin changes from scratching, such as excoriations, this is documented, but the presence of a primary skin rash would typically exclude you from trials specifically studying CKD-associated pruritus.^[4]

Additional Health Assessments

Clinical trials often include comprehensive health assessments beyond what’s needed for basic diagnosis. These might include tests to evaluate your overall health status, check for other complications of kidney disease, and ensure you don’t have conditions that could make the experimental treatment unsafe for you. Blood pressure measurements, heart function tests, and detailed blood work to check various body chemistry levels are commonly performed.

Quality of life assessments are frequently part of trial protocols, as researchers want to understand not just whether a treatment reduces itching, but whether it improves participants’ overall wellbeing, sleep quality, and ability to function in daily life. These assessments help demonstrate the real-world value of new treatments beyond just reducing symptoms.